fluticasone propionate inhaled
Selected indexed studies
- Inhaled salmeterol/fluticasone propionate: a review of its use in asthma. (Drugs, 2005) [PMID:16060707]
- Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. (Drugs, 2000) [PMID:11129128]
- Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease. (Am J Respir Med, 2002) [PMID:14720047]
_Worker-drafted node — pending editorial review._
Connections
fluticasone propionate inhaled is a side effect of
Sources
- Salmeterol/fluticasone propionate combination. (1999) pubmed
- Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study. (2024) pubmed
- Inhaled salmeterol/fluticasone propionate: a review of its use in asthma. (2005) pubmed
- Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. (2000) pubmed
- Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease. (2002) pubmed
- Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma. (1994) pubmed
- Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma. (2000) pubmed
- Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. (2003) pubmed
- Efficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma. (2017) pubmed
- Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability. (2024) pubmed